BMS-232632

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BMS-232632, covering 2011-05-04 to 2016-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome [Phase 4]